Table of Contents

Articles

• You have access

  Ibrutinib Blocks YAP1 Activation and Reverses BRAF Inhibitor Resistance in Melanoma Cells

  Sean A. Misek, Patrick A. Newbury, Evgenii Chekalin, Shreya Paithankar, Andrea I. Doseff, Bin Chen, Kathleen A. Gallo and Richard R. Neubig

  Molecular Pharmacology January 2022, 101 (1) 1-12; DOI: https://doi.org/10.1124/molpharm.121.000331
• You have access

  Chrysosplenol-C Increases Contraction by Augmentation of Sarcoplasmic Reticulum Ca²⁺ Loading and Release via Protein Kinase C in Rat Ventricular Myocytes

  J. Wang, T.N. Trinh, A. T. V. Vu, J.C. Kim, A.T.N. Hoang, C.J. Ohk, Y.H. Zhang, C.M. Nguyen and S.H. Woo

  Molecular Pharmacology January 2022, 101 (1) 13-23; DOI: https://doi.org/10.1124/molpharm.121.000365
• You have access

  Structural Basis of the Negative Allosteric Modulation of 5-BDBD at Human P2X4 Receptors

  Stefan Bidula, Izzuddin Bin Nadzirin, Marco Cominetti, Harry Hickey, Sean A. Cullum, Mark Searcey, Ralf Schmid and Samuel J. Fountain

  Molecular Pharmacology January 2022, 101 (1) 33-44; DOI: https://doi.org/10.1124/molpharm.121.000402
• You have access

  Decoding Cinnabarinic Acid–Specific Stanniocalcin 2 Induction by Aryl Hydrocarbon Receptor

  Nikhil Y. Patil, Hui Tang, Iulia Rus, Kangling Zhang and Aditya D. Joshi

  Molecular Pharmacology January 2022, 101 (1) 45-55; DOI: https://doi.org/10.1124/molpharm.121.000376
• 

  Open Access

  Steroidal Antagonists of Progesterone- and Prostaglandin E₁-Induced Activation of the Cation Channel of Sperm

  Erick J. Carlson, Gunda I. Georg and Jon E. Hawkinson

  Molecular Pharmacology January 2022, 101 (1) 56-67; DOI: https://doi.org/10.1124/molpharm.121.000349